Jessica Ringena has been named the newest president of Amber Specialty Pharmacy. Prior to joining Hy-Vee, Ringena was president of Vivid Clear Rx, a pharmacy benefit manager.

Ringena, who is renowned for her strategic leadership in the fields of innovation, technology, finance, and health care, will guide the specialized pharmacy in fulfilling its goal of providing patients with complex and long-term care that is tailored to their individual needs. From previous positions at Vivid Clear Rx and Hy-Vee, where she was an expert at utilizing technology to improve health care results, Ringena brings a wealth of knowledge to the table. Her idea of incorporating state-of-the-art digital technologies is in line with Amber Specialty Pharmacy’s objective of providing patients with outstanding care.

Aaron Wiese, president of Hy-Vee, stated, As we continue to build upon our partnerships with providers, manufacturers, and payers at Amber Specialty Pharmacy and further our commitment to patient care, Jessica’s deep understanding of the health care landscape and expertise in digital innovation will be crucial.

For 25 years, Amber Specialty Pharmacy has been offering individualized care to patients all throughout the United States. The provider specializes in oncology, rare/orphan medications, transplant, infusion, and specialty care. Awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy in 2020, Amber Specialty Pharmacy provides a complete care approach that includes therapy-specific counseling, medication management, and round-the-clock clinical assistance.

Before joining Hy-Vee, the parent company of Amber Specialty Pharmacy, Ringena was employed at RSM US, LLP. She began working at their Des Moines, Iowa, office in 2003 and advanced to the position of senior manager of audit during that period. Ringena began working for Hy-Vee in 2015 as an assistant vice president of financial reporting. Later, she was given the responsibility of controller. She received a promotion to vice president of business development and innovation in 2017. In the years that followed, she held a number of significant positions, including senior vice president and chief revenue officer, senior vice president and chief digital officer, and senior vice president of finance and business strategy. Ringena assumed the role of president of Vivid Clear Rx, the pharmaceutical benefit manager recently launched by Hy-Vee, in 2022.

Amber Specialty Pharmacy, a pioneer in specialty pharmacy services, provides cutting-edge patient care by fusing individualized attention with technologically advanced solutions. Exceptionally supporting patients with complicated and long-term ailments nationwide, Amber Specialty pharmaceutical is an independently run pharmaceutical provider and a division of Hy-Vee, Inc., an employee-owned $13+ billion store.

Tagged